File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Regression of left ventricular hypertrophy after treatment of hypertension: Comparison of directed M-echocardiography with magnetic resonance imaging in quantification of serial mass changes

TitleRegression of left ventricular hypertrophy after treatment of hypertension: Comparison of directed M-echocardiography with magnetic resonance imaging in quantification of serial mass changes
Authors
KeywordsChemicals And Cas Registry Numbers
Issue Date2003
PublisherChurchill Livingstone. The Journal's web site is located at http://www.elsevier.com/locate/cardfail
Citation
Journal Of Cardiac Failure, 2003, v. 9 n. 2, p. 122-127 How to Cite?
AbstractBackground: This study sought to validate the reliability of serial echocardiographic measurements in detecting left ventricular (LV) hypertrophy regression by using magnetic resonance imaging (MRI) as a reference standard. Methods and Results: We studied a small population (n = 20) of patients enrolled in the Prospective Randomized Enalapril Study Evaluating Regression of Ventricular Enlargement (PRESERVE) trial for evaluating LV hypertrophy regression. LV mass was measured by both echocardiography and MRI at baseline and after 1 year. As compared with baseline, systolic and diastolic blood pressures were significantly decreased after 1 year (all P < .05). Echocardiographic technique showed an overestimation of LV mass by 27.6 g at baseline (P = .005) and by 37.1 g after 1 year (P < .001), and there were wide 95% limits of agreement (±36.0 g at baseline; and ±27.6 g after 1 year) when compared with MRI measurement. Significant changes of LV mass from baseline of -20 ± 22 g (P < .01) and -29 ± 19 g (P < .01) were detected by using echocardiography and MRI after 1 year, respectively (P = .02), and there were similarly wide limits of agreement for change in LV mass (±24.2 g). Conclusions: Despite the use of careful methodology, echocardiographic measurement of LV mass at a single time point or for serial studies resulted in significant variation in LV mass estimates from measurement using MRI.
Persistent Identifierhttp://hdl.handle.net/10722/91532
ISSN
2023 Impact Factor: 6.7
2023 SCImago Journal Rankings: 1.970
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorTse, HFen_HK
dc.contributor.authorCheung, BMYen_HK
dc.contributor.authorNg, Wen_HK
dc.contributor.authorChan, JKFen_HK
dc.contributor.authorDevereux, RBen_HK
dc.contributor.authorLau, CPen_HK
dc.date.accessioned2010-09-17T10:20:56Z-
dc.date.available2010-09-17T10:20:56Z-
dc.date.issued2003en_HK
dc.identifier.citationJournal Of Cardiac Failure, 2003, v. 9 n. 2, p. 122-127en_HK
dc.identifier.issn1071-9164en_HK
dc.identifier.urihttp://hdl.handle.net/10722/91532-
dc.description.abstractBackground: This study sought to validate the reliability of serial echocardiographic measurements in detecting left ventricular (LV) hypertrophy regression by using magnetic resonance imaging (MRI) as a reference standard. Methods and Results: We studied a small population (n = 20) of patients enrolled in the Prospective Randomized Enalapril Study Evaluating Regression of Ventricular Enlargement (PRESERVE) trial for evaluating LV hypertrophy regression. LV mass was measured by both echocardiography and MRI at baseline and after 1 year. As compared with baseline, systolic and diastolic blood pressures were significantly decreased after 1 year (all P < .05). Echocardiographic technique showed an overestimation of LV mass by 27.6 g at baseline (P = .005) and by 37.1 g after 1 year (P < .001), and there were wide 95% limits of agreement (±36.0 g at baseline; and ±27.6 g after 1 year) when compared with MRI measurement. Significant changes of LV mass from baseline of -20 ± 22 g (P < .01) and -29 ± 19 g (P < .01) were detected by using echocardiography and MRI after 1 year, respectively (P = .02), and there were similarly wide limits of agreement for change in LV mass (±24.2 g). Conclusions: Despite the use of careful methodology, echocardiographic measurement of LV mass at a single time point or for serial studies resulted in significant variation in LV mass estimates from measurement using MRI.en_HK
dc.languageengen_HK
dc.publisherChurchill Livingstone. The Journal's web site is located at http://www.elsevier.com/locate/cardfailen_HK
dc.relation.ispartofJournal of Cardiac Failureen_HK
dc.subjectChemicals And Cas Registry Numbersen_HK
dc.subject.meshAgeden_HK
dc.subject.meshAntihypertensive Agents - therapeutic useen_HK
dc.subject.meshCalcium Channel Blockers - therapeutic useen_HK
dc.subject.meshEchocardiographyen_HK
dc.subject.meshEnalapril - therapeutic useen_HK
dc.subject.meshFemaleen_HK
dc.subject.meshHumansen_HK
dc.subject.meshHypertension - drug therapyen_HK
dc.subject.meshHypertrophy, Left Ventricular - diagnosis - prevention & control - ultrasonographyen_HK
dc.subject.meshMagnetic Resonance Imagingen_HK
dc.subject.meshMaleen_HK
dc.subject.meshNifedipine - therapeutic useen_HK
dc.titleRegression of left ventricular hypertrophy after treatment of hypertension: Comparison of directed M-echocardiography with magnetic resonance imaging in quantification of serial mass changesen_HK
dc.typeArticleen_HK
dc.identifier.emailTse, HF:hftse@hkucc.hku.hken_HK
dc.identifier.emailCheung, BMY:mycheung@hku.hken_HK
dc.identifier.authorityTse, HF=rp00428en_HK
dc.identifier.authorityCheung, BMY=rp01321en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1054/jcaf.2003.12en_HK
dc.identifier.pmid12751133-
dc.identifier.scopuseid_2-s2.0-0037388920en_HK
dc.identifier.hkuros99478-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0037388920&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume9en_HK
dc.identifier.issue2en_HK
dc.identifier.spage122en_HK
dc.identifier.epage127en_HK
dc.identifier.isiWOS:000182332900008-
dc.publisher.placeUnited Statesen_HK
dc.identifier.scopusauthoridTse, HF=7006070805en_HK
dc.identifier.scopusauthoridCheung, BMY=7103294806en_HK
dc.identifier.scopusauthoridNg, W=7401613562en_HK
dc.identifier.scopusauthoridChan, JKF=7403287057en_HK
dc.identifier.scopusauthoridDevereux, RB=36013369000en_HK
dc.identifier.scopusauthoridLau, CP=7401968501en_HK
dc.identifier.issnl1071-9164-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats